Health officials removing cancer and dementia warnings from hormone therapy drugs
Health officials plan to remove labels warning of dementia and cancer from hormone-replacement therapy drugs for women.
The US Department of Health and Human Services (HHS) announced Monday that the FDA is initiating the removal of ‘black box’ warnings from hormone replacement therapy (HRT) drugs used to treat menopause.
HRT involves replacing hormones that have naturally declined in the body such as estrogen and progesterone. During menopause, which starts on average for women at age 51, a woman’s eggs naturally begin producing less estrogen.
This leads to the tell-tale signs of menopause such as hot flashes, vaginal dryness, bladder issues and low sex drive.
HRT helps restore estrogen levels and has been shown alleviate menopause symptoms, yet only one in 20 women in the US receive the treatment.
